Replies to post #93711 on PharmaCyte Biotech Inc (PMCB)

[ace1234]

Final stages of planning? Idk but interesting catch

[rcstock]

Final Stages of optimization are studies and tests. BEFORE the production runs. So, we don't know how long the "studies" will take.

[DragonBear]

Plans ?? Does that mean the runs haven't started yet? After the runs they have to be tested? How long would this take?

It seems to suggest the two "staggered" runs haven't started. Neither is there any firm timeline to start em, or give, what they are trying to test, or how long to complete. Kenny doesn't like timelines. He also doesn't like to tell SHs what problem(s) are being solved. Better to keep SH expectations more manageable by keeping them in the dark.

They say "PharmaCyte and Austrianova and its team of consultants are in the final stages of optimizing this aspect of the manufacturing process."

Do these statements conflict with each other? One says plans, and the other says final stages.

"Manufacturing runs" is the latest Kenny code saying: Pre-production, and that final pre-production run from last 18-Sep-18 wasn't final. Neither was the implied production run (e.g. to generate mythical CT CIABS) a production run. That mutated into a Manufacturing run today.

One might say they are planing an undefined number of Manufacturing runs. Sure they now say 2. After saying no more were needed last Sep. If SHs ask how many more, the predicted reply will be to tell SHs they have to be "patient".

Basically Kenny has things setup to go back in time before Sep. Depending on what's being tested (or pretending to be tested), other pre-clinical tests might have to be repeated.

This year started with Kenny watching the cells grow on 15-Jan. Implying it was a production run, with production run data including QC to be plugged into the mythical IND for FDA submission. Now they are planning to tweak something (or pretending to), so as to define the manufacturing process. That part would go into the mythical IND as it was suppose to have been last Sep. But, no mythical CT material. No mythical IND submission. Quite a turnaround from the SH expectations of last Jan.